Stage IV Nasopharyngeal Cancer
1 clinical trials · Condition
◉ Watch Stage IV Nasopharyngeal Cancer
| Record | Firm | Date |
|---|---|---|
| Bortezomib and Gemcitabine in Treating Patients With Recurrent or Metastatic Nasopharyngeal Cancer (NCT00305734) | National Cancer Institute (NCI) | 2006-08-01 |
Track Stage IV Nasopharyngeal Cancer automatically
Every clearance here is in the API, with alerts when new ones post.